☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Locally Advanced
Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval for Expanded Indication in Patients with Locally Advanced Cutaneou...
July 6, 2021
Merck KGaA and Pfizer's Bavencio (avelumab) Receive the US FDA's Approval as a 1L Treatment for Locally Advanced or Metastatic Uro...
July 1, 2020
Merck KGaA and Pfizer Report EMA's Validation for Bavencio (avelumab) as a 1L Treatment for Locally Advanced or Metastatic Urothel...
June 22, 2020
Samsung Bioepis Reports Results of Ontruzant (biosimilar- trastuzumab) in P-III Follow-up Study (SB3-G31-BC-E) for Early or Locall...
May 15, 2020
EMD Serono and Pfizer's Bavencio (avelumab) Receive the US FDA's Breakthrough Therapy Designation as 1L Maintenance Treatment of L...
April 9, 2020
Merck KGaA and Pfizer Report Results of Bavencio (avelumab) in P-III JAVELIN Bladder 100 Study for Patients with Locally Advanced...
January 7, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.